Menu
 
Research menu
Jump to menu

Publications:  Prof Anthony Warrens

Chowdhury TA, Khan H, Druce MR, Drake WM, Rajakariar R, Thuraisingham R, Dobbie H, Parvanta L et al.(2019). Flipped learning: Turning medical education upside down. Future Healthc J vol. 6, (3) 192-195.
10.7861/fhj.2018-0017
Tong A, Manns B, Wang AYM, Hemmelgarn B, Wheeler DC, Gill J, Tugwell P, Pecoits-Filho R et al.(2018). Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop. Kidney International vol. 94, (6) 1053-1068.
10.1016/j.kint.2018.08.018
Sautenet B, Tong A, Chapman JR, Warrens AN, Rosenbloom D, Wong G, Gill J, Budde K et al. (2018). Range and Consistency of Outcomes Reported in Randomized Trials Conducted in Kidney Transplant Recipients: A Systematic Review. Transplantation. vol. 102, 2065-2071.
10.1097/TP.0000000000002278
Sautenet B, Tong A, Manera K, Chapman J, Warrens A, Rosenbloom D, Wong G, Gill J et al. (2017). DEVELOPING CONSENSUS-BASED PRIORITY OUTCOME DOMAINS FOR TRIALS IN KIDNEY TRANSPLANTATION: A MULTINATIONAL DELPHI SURVEY WITH PATIENTS, CAREGIVERS AND HEALTH PROFESSIONALS. TRANSPLANT INTERNATIONAL. vol. 30, 557-557.
Tong A, Gill J, Budde K, Marson L, Reese P, Rostaing L, Rosenbloom D, Wong G et al. (2017). TOWARD ESTABLISHING CORE OUTCOME DOMAINS FOR TRIALS IN KIDNEY TRANSPLANTATION: REPORT OF THE STANDARDIZED OUTCOMES IN NEPHROLOGY - KIDNEY TRANSPLANTATION (SONG-TX) CONSENSUS WORKSHOPS. TRANSPLANT INTERNATIONAL. vol. 30, 52-53.
Sautenet B, Tong A, Manera KE, Chapman JR, Warrens AN, Rosenbloom D, Wong G, Gill J et al.(2017). Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation: A Multinational Delphi Survey With Patients, Caregivers, and Health Professionals. Transplantation vol. 101, (8) 1875-1886.
10.1097/TP.0000000000001776
Tong A, Gill J, Budde K, Marson L, Reese PP, Rosenbloom D, Rostaing L, Wong G et al.(2017). Toward Establishing Core Outcome Domains for Trials in Kidney Transplantation: Report of the Standardized Outcomes in Nephrology-Kidney Transplantation Consensus Workshops. Transplantation vol. 101, (8) 1887-1896.
10.1097/TP.0000000000001774
Sautenet B, Tong A, Manera K, Chapman J, Warrens A, Rosenbloom D, Wong G, Gill J et al. (2017). DEVELOPING CONSENSUS BASED PRIORITY OUTCOME DOMAINS FOR TRIALS IN KIDNEY TRANSPLANTATION: A MULTINATIONAL DELPHI SURVEY WITH PATIENTS, CAREGIVERS AND HEALTH PROFESSIONALS. NEPHROLOGY DIALYSIS TRANSPLANTATION. vol. 32,
Sautenet B, Tong A, Chapman J, Warrens A, Rosenbloom D, Wong G, Gill J, Budde K et al. (2017). THE BREADTH AND CONSISTENCY OF OUTCOMES REPORTED IN RANDOMISED TRIALS CONDUCTED IN ADULT KIDNEY TRANSPLANT RECIPIENTS. NEPHROLOGY DIALYSIS TRANSPLANTATION. vol. 32,
Druce MR, Hickey A, Warrens AN, Westwood OMR(2016). Medical Students Raising Concerns. Journal of Patient Safety
10.1097/PTS.0000000000000313
https://qmro.qmul.ac.uk/xmlui/handle/123456789/23054
Tong A, Budde K, Gill J, Josephson MA, Marson L, Pruett TL, Reese PP, Rosenbloom D et al.(2016). Standardized Outcomes in Nephrology-Transplantation. Transplantation direct vol. 2, (6) e79-e79.
10.1097/TXD.0000000000000593
https://qmro.qmul.ac.uk/xmlui/handle/123456789/15116
Tano N, Kaneko M, Ichihara Y, Ikebe C, Coppen SR, Shiraishi M, Shintani Y, Yashiro K et al.(2016). Allogeneic mesenchymal stromal cells transplanted onto the heart surface achieve therapeutic myocardial repair despite immunologic responses in rats. Journal of the American Heart Association vol. 5, (2)
10.1161/JAHA.115.002815
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12778
Buffin J, Little R, Jain N, Warrens AN(2015). A peer outreach initiative to increase the registration of minorities as organ donors. Clin Kidney J vol. 8, (5) 623-628.
10.1093/ckj/sfv066
Onions L, Gupta A, Martin J, Puliatti C, Cacciola R, Navarrete C, Warrens A (2014). Renal Transplant Status Correlates With Expression of BAFF and Localises Within Intra-Graft Lymphoid Aggregates During Acute Antibody-Mediated Rejection. TRANSPLANTATION. vol. 98, 221-221.
Onions L, Gupta A, Martin J, Puliatti C, Cacciola R, Navarrete C, Warrens A (2014). Renal Transplant Status Correlates With Expression of BAFF and Localises Within Intra-Graft Lymphoid Aggregates During Acute Antibody-Mediated Rejection. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 14, 221-221.
Dierselhuis MP, Spierings E, Drabbels J, Hendriks M, Alaez C, Alberú J, Alvarez MB, Burlingham W et al.(2013). Minor H antigen matches and mismatches are equally distributed among recipients with or without complications after HLA identical sibling renal transplantation. Tissue Antigens vol. 82, (5) 312-316.
10.1111/tan.12209
Gauher ST, Khehar R, Rajput G, Hayat A, Bakshi B, Chawla H, Cox BM, Warrens AN(2013). The factors that influence attitudes toward organ donation for transplantation among UK university students of Indian and Pakistani descent. Clin Transplant vol. 27, (3) 359-367.
10.1111/ctr.12096
Lawrence C, Willicombe M, Brookes P, Santos-Nunez E, Roufosse C, Warrens A, Taube D (2013). Complement-Activating DSA: Which Assay in Which Setting?. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 13, 141-141.
Lawrence C, Willicombe M, Brookes P, Clarke C, Santos-Nunez E, Roufosse C, Warrens A, Taube D (2013). Complement-Activating Low-Level Preformed Donor-Specific Antibodies Detected by C1qScreen (TM) Predict Early Antibody-Mediated Rejection in Renal Allografts. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 13, 140-141.
Warrens AN(2012). Organ Donation and Priority Points in Israel. TRANSPLANTATION vol. 94, (7) E42-E42.
10.1097/TP.0b013e318266914e
Mazaris EM, Warrens AN, Smith G, Tekkis P, Papalois VE(2012). Live kidney donation: attitudes towards donor approach, motives and factors promoting donation. Nephrol Dial Transplant vol. 27, (6) 2517-2525.
10.1093/ndt/gfr642
Warrens AN, Lovell H, UK Donation Ethics Committee(2012). Addressing problems in transplantation research in the United kingdom. Transplantation vol. 93, (9) 860-864.
10.1097/TP.0b013e31824cd589
Lawrence C, Willicombe M, Brookes P, Santos-Nunez E, Roufosse C, Cook T, Warrens A, Taube D (2012). A Composite Risk Score Is Highly Specific for Predicting Outcomes in Renal Transplant Recipients with De Novo Donor-Specific Antibody. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 12, 364-365.
Lawrence C, Willicombe M, Brookes P, Santos-Nunez E, Roufosse C, Cook T, Warrens AN, Taube D (2012). Complement (C1q)-Fixing De Novo Donor-Specific Antibodies Predict Renal Allograft Loss, Antibody Mediated Rejection and Transplant Glomerulopathy. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 12, 183-183.
Warrens AN, Birch R, Collett D, Daraktchiev M, Dark JH, Galea G, Gronow K, Neuberger J et al.(2012). Advising potential recipients on the use of organs from donors with primary central nervous system tumors. Transplantation vol. 93, (4) 348-353.
10.1097/TP.0b013e31823f7f47
Mazaris EM, Crane JS, Warrens AN, Smith G, Tekkis P, Papalois VE(2012). Live donor kidney transplantation: attitudes of patients and health care professionals concerning the pre-surgical pathway and post-surgical follow-up. Int Urol Nephrol vol. 44, (1) 157-165.
10.1007/s11255-011-9987-9
Nestel D, Ivkovic A, Hill RA, Warrens AN, Paraskevas PA, McDonnell JA, Mudarikwa RS, Browne C(2012). Benefits and challenges of focus groups in the evaluation of a new Graduate Entry Medical Programme. ASSESSMENT & EVALUATION IN HIGHER EDUCATION vol. 37, (1) 1-17.
10.1080/02602938.2010.494232
Tarzi RM, Sharp PEH, McDaid JP, Fossati-Jimack L, Herbert PE, Pusey CD, Cook HT, Warrens AN(2012). Mice with defective Fas ligand are protected from crescentic glomerulonephritis. Kidney Int vol. 81, (2) 170-178.
10.1038/ki.2011.319
Chan K, Taube D, Roufosse C, Cook T, Brookes P, Goodall D, Galliford J, Cairns T et al.(2011). Kidney transplantation with minimized maintenance: alemtuzumab induction with tacrolimus monotherapy--an open label, randomized trial. Transplantation vol. 92, (7) 774-780.
10.1097/TP.0b013e31822ca7ca
Willicombe M, Roufosse C, Brookes P, Galliford JW, McLean AG, Dorling A, Warrens AN, Cook TH et al.(2011). Antibody-mediated rejection after alemtuzumab induction: incidence, risk factors, and predictors of poor outcome. Transplantation vol. 92, (2) 176-182.
10.1097/TP.0b013e318222c9c6
Mazaris EM, Crane JS, Warrens AN, Smith G, Tekkis P, Papalois VE(2011). Attitudes toward live donor kidney transplantation and its commercialization. Clin Transplant vol. 25, (3) E312-E319.
10.1111/j.1399-0012.2011.01418.x
Lawrence C, Willicombe M, Brookes P, Santos-Nunez E, Bajaj R, Cook T, Roufosse C, Taube D et al. (2011). Preformed Anti-HLA -A, -B and -DR but Not -DQ Complement-Activating Low-Level Donor- Specific Antibodies Predict Early Antibody- Mediated Rejection in Renal Allografts. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 11, 471-472.
10.1097/TP.0b013e3182743cfa
Willicombe M, Brookes P, Santos-Nunez E, Galliford J, Ballow A, Mclean A, Roufosse C, Cook HT et al.(2011). Outcome of patients with preformed donor-specific antibodies following alemtuzumab induction and tacrolimus monotherapy. Am J Transplant vol. 11, (3) 470-477.
10.1111/j.1600-6143.2010.03421.x
Miqueu P, Degauque N, Guillet M, Giral M, Ruiz C, Pallier A, Braudeau C, Roussey-Kesler G et al.(2010). Analysis of the peripheral T-cell repertoire in kidney transplant patients. Eur J Immunol vol. 40, (11) 3280-3290.
10.1002/eji.201040301
Willicombe M, Santos-Nunez E, Brookes P, Galliford J, Stubbs N, Mclean A, Roufosse C, Cook T et al.(2010). Preformed donor specific antibodies are associated with high incidence of antibody mediated rejection despite Alemtuzumab induction. INT J IMMUNOGENET vol. 37, (5) 419-419.
Miqueu P, Degauque N, Guillet M, Giral M, Ruiz C, Pallier A, Braudeau C, Roussey-Kesler G et al.(2010). Analysis of the peripheral T-cell repertoire in kidney transplant patients. Eur J Immunol
10.1002/eji.201040301
Bajaj R, Brookes P, Warrens A (2010). C4D FIXATION ON BEADS AS A MARKER FOR C4D STAINING ON RENAL BIOPSIES. NEPHROLOGY. vol. 15, 72-72.
Sagoo P, Perucha E, Sawitzki B, Tomiuk S, Stephens DA, Miqueu P, Chapman S, Craciun L et al.(2010). Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest vol. 120, (6) 1848-1861.
10.1172/JCI39922
Galliford J, Chan K, Lawrence C, Willicombe M, Charif R, Roufosse C, Cook HT, Warrens AN et al. (2010). Antibody Mediated Rejection after ABO Incompatible Living Donor Renal Transplantation Is Mainly Associated with HLA Donor Specific Antibodies. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 10, 164-164.
Willicombe M, Brookes P, Galliford J, McLean A, Warrens A, Cairns T, Taube D (2010). De Novo Donor Specific Antibodies Are Associated with Antibody Mediated Rejection in Patients Receiving Alemtuzumab Induction. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 10, 234-235.
Willicombe M, Galliford J, Corbett R, Filiopoulis V, McLean A, Roufosse C, Warrens A, Cairns T et al. (2010). Donor Specific Antibody Titres Predict Antibody Mediated Rejection and Response to Treatment. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 10, 234-234.
Jain N, Hoyle T, Warrens A (2010). Organ Donation in Black and Minority Ethnic Communities in the UK: Using Peer Educators To Access Hitherto "Hard-to-Reach" Populations. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 10, 289-289.
Willicombe M, Brookes P, Galliford J, McLean A, Warrens A, Cairns T, Taube D (2010). Preformed Donor Specific Antibodies Are Associated with High Incidence of Antibody Mediated Rejection Despite Alemtuzumab Induction. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 10, 164-164.
Ambrose LR, Morel A-S, Warrens AN(2009). Neutrophils express CD52 and exhibit complement-mediated lysis in the presence of alemtuzumab. Blood vol. 114, (14) 3052-3055.
10.1182/blood-2009-02-203075
McLean A, Chan KK, Galliford J, Goodall D, Charif R, Dorling A, Warrens A, Cairns T et al.(2009). RANDOMISED CONTROLLED TRIAL OF ALEMTUZUMAB-TACROLIMUS MONOTHERAPY WITH DACLIZUMAB-TACROLIMUS-MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANTATION. TRANSPL INT vol. 22, 91-91.
Mazaris EM, Warrens AN, Papalois VE(2009). Ethical issues in live donor kidney transplant: views of medical and nursing staff. Exp Clin Transplant vol. 7, (1) 1-7.
McDermott J, Rice B, Harcourt N, Ayton-Tyler J, Reece P, Dulku H, Chan EK, Papalois V et al. (2009). Ethnicity May Not Be a Factor in Determining Availability of Live Donors. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 9, 604-604.
Chan K, Galliford J, Goodall D, Charif R, Dorling A, Warrens A, Hakim N, Papalois V et al. (2009). Randomised Controlled Trial of Alemtuzumab and Tacrolimus Monotherapy with Daclizumab, Tacrolimus and Mycophenolate Mofetil in Renal Transplantation. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 9, 282-282.
Galliford J, Chan K, Willicombe M, Roufosse C, Hakim N, Papalois V, Warrens A, McLean A et al. (2009). Renal Allograft Rejection after Alemtuzumab Induction and Tacrolimus Monotherapy. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 9, 620-621.
Willicombe M, Chan K, Galliford J, Brookes P, Ballow A, Cairns T, Dorling A, Warrens A et al. (2009). Significance of Preformed Anti-HLA Antibodies in Patients Receiving Steroid Sparing Immunosuppression Protocols. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 9, 509-509.
Hernandez-Fuentes M, Perucha E, Sagoo P, Sawitzki B, Tomiuk S, Stephens DA, Miqueu P, Chapman S et al. (2009). Validated Biomarkers of Immune Tolerance in Renal Transplants. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 9, 624-624.
Ballow AA, Sergeant R, Hernandez-Fuentes MP, Warrens AN(2008). Post-transplant detection of anti-HLA antibody IgG subclasses. INT J IMMUNOGENET vol. 35, (6) 496-496.
Weng L, Addey C, Warrens AN, Dyson J, Chai J-G, Dazzi F(2008). Dissection of effector pathways in the host-versus-graft response to bone marrow transplantation. Transplantation vol. 86, (9) 1311-1314.
10.1097/TP.0b013e3181872878
Diamond H, Warrens A(2008). Jack Elius Miller Obituary. BRIT MED J vol. 337, Article a2439,
10.1136/bmj.a2439
Galliford J, Charif R, Chan KK, Loucaidou M, Cairns T, Cook HT, Dorling A, Hakim N et al.(2008). ABO incompatible living renal transplantation with a steroid sparing protocol. Transplantation vol. 86, (7) 901-906.
10.1097/TP.0b013e3181880c0f
Srikantha M, Sergeant R, Khan T, Lechler RI, Davey N, Hernandez-Fuentes MP, Warrens AN(2008). Retrospective tissue typing of the kidney donor from recipient urine. Kidney Int vol. 74, (7) 952-955.
10.1038/ki.2008.340
Herbert PE, Morgan MF, Berton I, Lechler RI, Dorling A, Williams G, Warrens AN(2008). A pig allograft model of antibody-mediated rejection. Transpl Immunol vol. 19, (3-4) 167-172.
10.1016/j.trim.2008.05.003
Chan K, Galliford J, Charif R, Betmouni R, Dorling A, Hakim N, McLean A, Papalois V et al. (2008). Campath and tacrolimus monotherapy without steroids or mycophenolate mofetil: 3 year results. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 8, 440-440.
Charif R, Chan K, Canelo R, Hakim N, McLean A, Palmer A, Papalois V, Warrens A et al. (2008). Campath induction and Tacrolimus monotherapy in simultaneous kidney and pancreas transplantation. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 8, 553-553.
Fuentes MH, Sawitzki B, Perucha E, Sagoo P, Miqueu P, Chapman S, Stephens D, Craciun L et al. (2008). Identification of immune tolerance in renal transplants. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 8, 292-292.
Chan K, Taube D, Galliford J, Charif R, Dorling A, Goodall D, Hakim N, Papalois V et al. (2008). Randomised controlled trial of campath and tacrolimus-monotherapy with daclizumab, tacrolimus and mycophenolate mofetil in renal transplantation; Interim results. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 8, 216-216.
Galliford JW, Chan K, McLean AG, Cook HT, Charif R, Dorling A, Warrens AN, Taube D (2008). Renal allograft rejection after Campath induction and medium dose tacrolimus monotherapy without steroids. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 8, 580-580.
Galliford J, Shiu K, Chan K, England M, Cook T, McLean A, Warrens A, Taube D et al. (2008). Treatment of late antibody mediated rejection in renal transplant recipients. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 8, 442-443.
White LH, Casian A, Hilton R, Macphee IAM, Marsh J, Sweny P, Trevitt R, Frankel AH et al.(2008). BK virus nephropathy in renal transplant patients in London. Transplantation vol. 85, (7) 1008-1015.
10.1097/TP.0b013e31816a32fc
Warrens AN, Baboolal K, Buist L, Dudley C, Koffman G, Lipkin G, Parrott N, Powis SH et al.(2008). Interpreting regulatory authority guidance on immunosuppressive therapy for renal transplantation: a response to the UK's National Institute for Clinical Excellence (NICE). Clin Nephrol vol. 69, (2) 67-76.
10.5414/cnp69067
Miqueu P, Guillet M, Giral M, Ruiz C, Braudeau C, Hernandez-Fuentes M, Le Moine A, Sawitzki B et al. (2008). T cell repertoire analysis of stable kidney graft recipients for detection of low and high risk of chronic rejection. CLINICAL IMMUNOLOGY. vol. 127, S74-S75.
10.1016/j.clim.2008.03.208
Steggar C, Brookes P, Davey N, Warrens A(2007). The effect of pre-transplant autoantibodies on renal transplantation outcome. INT J IMMUNOGENET vol. 34, (4) 308-308.
Hernandez-Fuentes MP, Sawitzki B, Sagoo P, Craciun L, Brouard S, Perucha E, Chapman S, Bradeau C et al. (2007). Biomarkers of tolerance in kidney transplants. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 7, 337-337.
Sawitzki BS, Hernandez-Fuentes M, Sagoo P, Perucha E, Lemoine A, Brouard S, Chapman S, Peters B et al. (2007). Identification of tolerant patients based on a combinational analysis of foxp3 and aMannosidase transcription. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 7, 488-488.
Srikantha M, Sergeant R, Hernandez-Fuentes M, Lechler RI, Warrens AN (2007). Is it possible totissue type a kidney donor who is no longer available?. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 7, 268-268.
Kumar R, Herbert PE, Warrens AN (2007). Mechanisms of action of TRAIL in inhibiting immune response to alogeneic tissue. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 7, 148-148.
Sagoo P, Sawitzki B, Hernandez-Fuentes M, Perucha E, Craciun L, Brouard S, Chaprnan S, Bradeau C et al. (2007). Monitoring peripheral blood regulatory T cells on clinically defined groups of kidney transplant recipients. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 7, 340-340.
Ambrose LR, Smith LM, Little MAP, Dupont PJ, Warrens AN (2007). Neutrophils as antigen-presenting cells: Bridging innate and adaptive immunity. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 7, 412-412.
Villegas-Mendez A, Montes R, Ambrose LR, Warrens AN, Laffan M, Lane DA(2007). Proteolysis of the endothelial cell protein C receptor by neutrophil proteinase 3. J Thromb Haemost vol. 5, (5) 980-988.
10.1111/j.1538-7836.2007.02480.x
Hernandez-Fuentes MP, Sagoo P, Sawitzki B, Perucha E, Jimenez-Vera E, Craciun L, Brouard S, Chapman S et al. (2007). Tregs in peripheral blood of clinically defined groups of renal transplant recipients. IMMUNOLOGY. vol. 120, 10-10.
Dupont PJ, Warrens AN(2007). Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation. Immunology vol. 120, (1) 133-139.
10.1111/j.1365-2567.2006.02504.x
Onions L, Brookes P, Mclean A, Taube D, Warrens A, Dorling A, Salama A (2007). Generation of regulatory T cells in renal transplant recipients following induction therapy with Campath-1H and Daclizumab. HUMAN IMMUNOLOGY. vol. 68, S39-S39.
10.1016/j.humimm.2007.08.071
Gjorgjimajkoska O, Sergeant R, Brookes P, Davey N, Warrens A (2006). Specific donor FasR and FasL genotypes may be associated with increased acute cellular rejection in renal transplant recipients. HUMAN IMMUNOLOGY. vol. 67, S104-S104.
10.1016/j.humimm.2006.08.158
Sergeant R, Khan T, Hernandez M, Davey N, Warrens A(2006). Typing of absent renal donors. INT J IMMUNOGENET vol. 33, (4) 326-326.
Ambrose L, Smith L, Little M, Dupont P, Williams G, Warrens A (2006). Neutrophils as antigen-presenting cells in transplantation: Bridging innate and adaptive immunity. NEPHROLOGY DIALYSIS TRANSPLANTATION. vol. 21, 549-549.
Dooldeniya MD, Dupont PJ, He X, Johnson RJ, Joshi T, Basra R, Johnston A, Warrens AN(2006). Renal transplantation in indo-asian patients in the UK. AM J TRANSPLANT vol. 6, (4) 761-769.
10.1111/j.1600-6143.2006.01262.x
Tuthill MH, Stratton J, Warrens AN(2006). Calcific uremic arteriolopathy presenting with small and large bowel involvement. J Nephrol vol. 19, (1) 115-118.
Isaacs JD, Rakshi J, Baker R, Brooks DJ, Warrens AN(2005). Chorea associated with thyroxine replacement therapy. Mov Disord vol. 20, (12) 1656-1657.
10.1002/mds.20603
Dooldeniya MD, Dupont PJ, Ambrose LR, Lechler RI, Simpson E, Dyson PJ, Warrens AN(2005). Fas ligand is a mediator of relative immune privilege in non-specialised peripheral tissue in inflammation. IMMUNOLOGY vol. 116, 44-44.
Ambrose LR, Smith LM, Little MA, Dupont PJ, Herbert PE, Williams G, Lombardi G, Warrens AN(2005). PMNs as APCs in transplantation: bridging innate and adaptive immunity. IMMUNOLOGY vol. 116, 48-48.
Alkhawari FS, Stimson GV, Warrens AN(2005). Attitudes toward transplantation in U.K. Muslim Indo-Asians in west London. Am J Transplant vol. 5, (6) 1326-1331.
10.1111/j.1600-6143.2005.00814.x
Mirenda V, Golshayan D, Read J, Berton I, Warrens AN, Dorling A, Lechler RI(2005). Achieving permanent survival of islet xenografts by independent manipulation of direct and indirect T-cell responses. Diabetes vol. 54, (4) 1048-1055.
10.2337/diabetes.54.4.1048
Herbert PE, Lynch M, Morgan F, Berton I, Eckersley R, Williams G, Blomley M, Warrens AN(2005). Cyclosporine A does not alter ultrasonic indices of renal blood flow: a potential tool for differentiating toxicity from acute rejection?. Transplantation vol. 79, (6) 731-734.
10.1097/01.tp.0000154916.71990.31
Kumar R, Herbert PE, Warrens AN(2005). An introduction to death receptors in apoptosis. Int J Surg vol. 3, (4) 268-277.
10.1016/j.ijsu.2005.05.002
Cardozo LAM, Rouw DB, Ambrose LR, Midulla M, Florey O, Haskard DO, Warrens AN(2004). The neutrophil: the unnoticed threat in xenotransplantation?. Transplantation vol. 78, (12) 1721-1728.
10.1097/01.tp.0000147341.40485.b4
Griffiths EJ, Nelson RE, Dupont PJ, Warrens AN(2004). Skewing of pretransplant anti-HLA class I antibodies of immunoglobulin G isotype solely toward immunoglobulin G1 subclass is associated with poorer renal allograft survival. Transplantation vol. 77, (11) 1771-1773.
10.1097/01.tp.0000129408.07168.40
Chen D, Morgan F, Berton I, Herbert PE, Lechler RI, Dorling A, Williams G, Warrens AN(2004). Developing a porcine transplantation model: efficient gene transfer into porcine vascular cells. Transplantation vol. 77, (9) 1443-1451.
10.1097/01.tp.0000120951.33082.64
Haji NI, Nelson RE, Jones MNA, Johnson RJ, De Silva M, Malde R, Warrens AN(2004). Will transplantation of kidneys from donors with blood group A2 into recipients with blood group B help British Indo-Asian patients with renal failure?. Transplantation vol. 77, (4) 630-633.
10.1097/01.tp.0000103728.05798.7e
Mirenda V, Read J, Berton I, Warrens A, Lechler R (2004). Porcine CTLA4-Ig as a species-specific reagent to prevent direct pathway xenospecific T cell sensitization. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 4, 449-449.
Dupont PJ, Griffiths EJ, Nelson RE, Warrens AN (2004). Pre-transplant anti-HLA class I antibodies of IgG isotype skewed solely towards the IgG, subclass are associated with poorer renal allograft survival. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 4, 257-257.
Dooldeniya MD, Dupont PJ, Ambrose LR, Herbert PE, Tzivanikis A, Fazekasova H, Lombardi G, Warrens AN (2004). Thymosin beta-4 sulphoxide - An anti-inflammatory peptide with novel immunosuppressant properties. AMERICAN JOURNAL OF TRANSPLANTATION. vol. 4, 195-195.
Hernandez-Fuentes MP, Warrens AN, Lechler RI(2003). Immunologic monitoring. Immunol Rev vol. 196, 247-264.
10.1046/j.1600-065x.2003.00092.x
James MJ, Belaramani L, Prodromidou K, Datta A, Nourshargh S, Lombardi G, Dyson J, Scott D et al.(2003). Anergic T cells exert antigen-independent inhibition of cell-cell interactions via chemokine metabolism. BLOOD vol. 102, (6) 2173-2179.
10.1182/blood-2003-02-0637
Alenzi FQ, Warrens AN(2003). Cellular and molecular themes in apoptosis. Wien Klin Wochenschr vol. 115, (15-16) 563-574.
10.1007/BF03040450
Mirenda V, Read J, Berton I, Warrens A, Dorling A, Lechler RI (2003). Porcine CTLA4-Ig as a specific reagent to prevent direct pathway xenospecific T cell sensitization. XENOTRANSPLANTATION. vol. 10, 484-484.
Dupont PJ, Dooldeniya M, Cook T, Warrens AN(2003). Role of duplex Doppler sonography in diagnosis of acute allograft dysfunction-time to stop measuring the resistive index?. Transpl Int vol. 16, (9) 648-652.
10.1007/s00147-003-0601-7
Chen D, Berton I, Herbert PE, Morgan MF, Williams G, Lechler RI, Dorling A, Warrens AN (2003). Successful in vivo transfection of non-dividing endothelium by DAPI-supplemented liposome-packaged DNA. XENOTRANSPLANTATION. vol. 10, 512-512.
Morgan MF, Berton I, Herbert PE, Williams G, Lechler RI, Dorling A, Warrens AN (2003). The development of a pig allograft model as a surrogate for hyperacute rejection in xenotransplantation. XENOTRANSPLANTATION. vol. 10, 528-528.
Dooldeniya MD, Morgan F, Dyson PJ, Warrens AN (2003). The role of graft expressed Fas-ligand in rejection. XENOTRANSPLANTATION. vol. 10, 485-485.
Ambrose L, Cardozo L, Rouw D, Midulla M, Warrens AN (2003). The role of polymorphonuclear granulocytes in the direct recognition of xenogeneic endothelium. XENOTRANSPLANTATION. vol. 10, 502-502.
Dupont P, Warrens AN(2003). The evolving role of sirolimus in renal transplantation. QJM vol. 96, (6) 401-409.
10.1093/qjmed/hcg072
Dooldeniya MD, Warrens AN(2003). Xenotransplantation: where are we today?. J R Soc Med vol. 96, (3) 111-117.
10.1258/jrsm.96.3.111
Warrens AN(2003). On the horizon: tailor-made immunosuppression in renal transplantation. Nephron Clin Pract vol. 94, (1) c5-10.
10.1159/000070818
Alenzi FQB, Marley SB, Lewis JL, Chandrashekran A, Warrens AN, Goldman JM, Gordon MY(2002). A role for the Fas/Fas ligand apoptotic pathway in regulating myeloid progenitor cell kinetics. Exp Hematol vol. 30, (12) 1428-1435.
10.1016/s0301-472x(02)00957-8
Warrens AN(2002). Biological therapy in transplantation: an update from the 19th International Congress of the Transplantation Society. Expert Opin Biol Ther vol. 2, (8) 993-996.
10.1517/14712598.2.8.993
Warrens AN(2002). Pharmacological control of the immune response in renal transplantation. BJU Int vol. 90, (8) 784-791.
10.1046/j.1464-410x.2002.03006.x
Dupont PJ, Dooldeniya M, Herbert P, Warrens AN(2002). Acute rejection occurs earlier and with greater frequency in living-donor versus cadaveric renal transplant recipients. J AM SOC NEPHROL vol. 13, 186A-186A.
Dupont P, Hunt I, Goldberg L, Warrens A(2002). Colchicine myoneuropathy in a renal transplant patient. Transpl Int vol. 15, (7) 374-376.
10.1007/s00147-002-0426-9
Theodore PR, Simon AR, Warrens AN, Sackstein R, Sykes M(2002). Porcine mononuclear cells adhere to human fibronectin independently of very late antigen-5: implications for donor-specific tolerance induction in xenotransplantation. Xenotransplantation vol. 9, (4) 277-289.
10.1034/j.1399-3089.2002.01086.x
Harvey CJ, Lynch M, Blomley MJ, Cosgrove DO, Eckersley RJ, Warrens AN(2001). Can renal arteriovenous transit time measured using bolus injections of the ultrasound microbubble levovist (SHU 508A) characterize the vasculopathy in acute renal allograft rejection?. RADIOLOGY vol. 221, 418-418.
Game DS, Warrens AN, Lechler RI(2001). Rejection mechanisms in transplantation. Wien Klin Wochenschr vol. 113, (20-21) 832-838.
Dupont P, Jackson J, Warrens A, Lightstone L(2001). Life-threatening thrombosis 18 years after first presentation of primary antiphospholipid antibody syndrome. Nephrol Dial Transplant vol. 16, (4) 843-845.
10.1093/ndt/16.4.843
Dupont PJ, Lightstone L, Clutterbuck EJ, Gaskin G, Pusey CD, Cook T, Warrens AN(2000). Lesson of the week: cholesterol emboli syndrome. BMJ vol. 321, (7268) 1065-1067.
10.1136/bmj.321.7268.1065
Warrens AN, Simon AR, Theodore PR, Sachs DH, Sykes M(2000). Cross-species compatibility of intercellular adhesion molecule-1 (CD54) with its ligands. Transplantation vol. 69, (3) 394-399.
10.1097/00007890-200002150-00015
Warrens AN(2000). The evolving role of mycophenolate mofetil in renal transplantation. QJM vol. 93, (1) 15-20.
10.1093/qjmed/93.1.15
Sofat N, Bell S, Turner J, Warrens AN(1999). A case of acute renal failure and compartment syndrome after an alcoholic binge. J Accid Emerg Med vol. 16, (4) 296-298.
10.1136/emj.16.4.296
Simon AR, Warrens AN, Sykes M(1999). Efficacy of adhesive interactions in pig-to-human xenotransplantation. Immunol Today vol. 20, (7) 323-330.
10.1016/s0167-5699(99)01485-1
Warrens AN, Simon AR, Theodore PR, Sykes M(1999). Human-porcine receptor-ligand compatibility within the immune system: relevance for xenotransplantation. Xenotransplantation vol. 6, (2) 75-78.
10.1034/j.1399-3089.1999.00020.x
Warrens AN, Waters JB, Salama AD, Lechler RI(1999). Improving the therapeutic monitoring of cyclosporin A. Clin Transplant vol. 13, (2) 193-200.
10.1034/j.1399-0012.1999.130207.x
Simon AR, Warrens AN, Yazzie NP, Seebach JD, Sachs DH, Sykes M(1998). Cross-species interaction of porcine and human integrins with their respective ligands: implications for xenogeneic tolerance induction. Transplantation vol. 66, (3) 385-394.
10.1097/00007890-199808150-00017
Theodore PR, Simon AR, Warrens AN, Sackstein R, Sykes M(1998). Divergence of integrin function in hematopoiesis in the pig to human xenogeneic combination: Implications for bone marrow induced donor-specific tolerance. EXP HEMATOL vol. 26, (8) 778-778.
Warrens AN, Simon AR, Theodore PR, Sachs DH, Sykes M(1998). Function of porcine adhesion molecules in a human marrow microenvironment. Transplantation vol. 66, (2) 252-259.
10.1097/00007890-199807270-00020
Dorling A, Riesbeck K, Warrens A, Lechler R(1997). Clinical xenotransplantation of solid organs. Lancet vol. 349, (9055) 867-871.
10.1016/S0140-6736(96)09404-4
Warrens AN, Jones MD, Lechler RI(1997). Splicing by overlap extension by PCR using asymmetric amplification: an improved technique for the generation of hybrid proteins of immunological interest. Gene vol. 186, (1) 29-35.
10.1016/s0378-1119(96)00674-9
Warrens AN(1997). Studies on the interaction of T-cells with major histocompatibility complex class II antigens. Clin Sci (Lond) vol. 92, (1) 25-36.
10.1042/cs0920025
Warrens AN, Dorling A, Lechler RI(1996). The prospects for xenotransplantation. QJM vol. 89, (12) 885-891.
10.1093/qjmed/89.12.885
Warrens AN, Salama A, Waters JB, Lechler RI(1996). Comparison of Neoral and Sandimmune preparations in renal transplant patients--improved pharmacokinetics with neoral. Transplant Proc vol. 28, (4) 2169-2170.
Hargreaves RE, Brehm RD, Tranter H, Warrens AN, Lombardi G, Lechler RI(1995). Definition of sites on HLA-DR1 involved in the T cell response to staphylococcal enterotoxins E and C2. Eur J Immunol vol. 25, (12) 3437-3444.
10.1002/eji.1830251235
Lombardi G, Warrens AN, Lechler RI(1995). Anergic T cells act as suppressor cells in vitro. Transplant Proc vol. 27, (1) 235-236.
Mason PD, Warrens AN, Lechler RI(1995). Could analysis of helper T-cell precursor frequencies be used as a predictive parameter in renal transplantation?. Transplant Proc vol. 27, (1) 230-231.
Warrens AN, Lechler RI(1994). Customised immunosuppression. Bone Marrow Transplant vol. 13, (6) 671-673.
Warrens AN, Zhang JY, Sidhu S, Watt DJ, Lombardi G, Sewry CA, Lechler RI(1994). Myoblasts fail to stimulate T cells but induce tolerance. Int Immunol vol. 6, (6) 847-853.
10.1093/intimm/6.6.847
Warrens AN, Lombardi G, Lechler RI(1994). Presentation and recognition of major and minor histocompatibility antigens. Transpl Immunol vol. 2, (2) 103-107.
10.1016/0966-3274(94)90036-1
Warrens AN, Heaton T, Sidhu S, Lombardi G, Lechler RI(1994). Transfected murine cells expressing HLA class II can be used to generate alloreactive human T cell clones. J Immunol Methods vol. 169, (1) 25-33.
10.1016/0022-1759(94)90121-x
Lam HC, Takahashi K, Ghatei MA, Warrens AN, Rees AJ, Bloom SR(1991). Immunoreactive endothelin in human plasma, urine, milk, and saliva. J Cardiovasc Pharmacol vol. 17 Suppl 7, S390-S393.
10.1097/00005344-199100177-00109
Warrens AN, Cassidy MJ, Takahashi K, Ghatei MA, Bloom SR(1990). Endothelin in renal failure. Nephrol Dial Transplant vol. 5, (6) 418-422.
10.1093/ndt/5.6.418
Warrens AN, Ron MA, Dawling S(1990). Positive diagnosis of self-medication with homatropine eye drops. Br J Psychiatry vol. 156, 124-125.
10.1192/bjp.156.1.124
Warrens AN, Heaton JM(1987). Thoracic outlet compression syndrome: the lack of reliability of its clinical assessment. Ann R Coll Surg Engl vol. 69, (5) 203-204.
WARRENS AN, BARNES PJ, COLE PJ, MITCHELL DN(1986). PULSED INTRAVENOUS METHYLPREDNISOLONE THERAPY FOR REFRACTORY SARCOIDOSIS. THORAX vol. 41, (9) 714-715.
MOLITOR PJA, WARRENS AN(1985). ACUTE ORCHITIS ASSOCIATED WITH HEPATITIS-B INFECTION. BRIT MED J vol. 291, (6500) 940-940.
Kurnick JT, Warrens AR, Moscicki RA, Leary CP(1983). T-cell subsets in human lymphocytes maintained in IL-2 medium after PHA or mixed lymphocyte reaction activation. Clin Immunol Immunopathol vol. 27, (3) 444-451.
10.1016/0090-1229(83)90096-x
KURNICK JT, AHERN AT, PINTO CE, WARRENS A, KARR RW, FULLER TC(1983). THE USE OF INVITRO PROPAGATED SOLUBLE ANTIGEN-SPECIFIC HUMAN T-CELL BLASTS AS HLA-D/DR REAGENTS. TRANSPLANT P vol. 15, (1) 113-117.
MOSCICKI R, WARRENS A, KURNICK JT, COLVIN RB(1982). HUMAN T-CELL SUBSET CHANGES IDENTIFIED BY MONOCLONAL-ANTIBODIES AFTER PHA STIMULATION. FED PROC vol. 41, (3) 328-328.
Return to top